BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 9085324)

  • 1. Retrospective pharmacoeconomic evaluation of dosing vecuronium by peripheral nerve stimulation versus standard clinical assessment in critically ill patients.
    Zarowitz BJ; Rudis MI; Lai K; Petitta A; Lulek M
    Pharmacotherapy; 1997; 17(2):327-32. PubMed ID: 9085324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients.
    Rudis MI; Sikora CA; Angus E; Peterson E; Popovich J; Hyzy R; Zarowitz BJ
    Crit Care Med; 1997 Apr; 25(4):575-83. PubMed ID: 9142020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pharmacoeconomic analysis of neuromuscular blocking agents in the operating room.
    Loughlin KA; Weingarten CM; Nagelhout J; Stevenson JG
    Pharmacotherapy; 1996; 16(5):942-50. PubMed ID: 8888091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous infusion versus intermittent bolus dosing of vecuronium in patients receiving therapeutic hypothermia after sudden cardiac arrest.
    Jurado LV; Gulbis BE
    Pharmacotherapy; 2011 Dec; 31(12):1250-6. PubMed ID: 22122185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective analysis of long-term use of nondepolarizing neuromuscular blocking agents in the intensive care unit, and guidelines for drug selection.
    Clarens DM; Kelly KJ; Gilliland SS; Kohls PK; Nahum A; Vance-Bryan K
    Pharmacotherapy; 1993; 13(6):647-55. PubMed ID: 7905621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agreement between muscle movement and peripheral nerve stimulation in critically ill pediatric patients receiving neuromuscular blocking agents.
    Peña O; Prestjohn S; Guzzetta CE
    Heart Lung; 2000; 29(5):309-18. PubMed ID: 10986525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-resistance to both atracurium- and vecuronium-induced neuromuscular blockade in a critically ill patient.
    Fish DN; Singletary TJ
    Pharmacotherapy; 1997; 17(6):1322-7. PubMed ID: 9399619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of implementation of neuromuscular blockade monitoring standards in a surgical intensive care unit.
    Frankel H; Jeng J; Tilly E; St Andre A; Champion H
    Am Surg; 1996 Jun; 62(6):503-6. PubMed ID: 8651538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Train-of-four: to use or not to use.
    Tschida SJ; Hoey LL; Mather D; Vance-Bryan K
    Pharmacotherapy; 1995; 15(4):546-50. PubMed ID: 7479212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
    MacLaren R; Bond CA
    Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic aspects of different muscle relaxant regimens.
    Suttner S; Boldt J; Piper SN; Schmidt C; Kumle B
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2000 May; 35(5):300-5. PubMed ID: 10858839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of peripheral nerve stimulators to monitor patients with neuromuscular blockade in the ICU.
    Kleinpell R; Bedrosian C; McCormick L; Kremer M; Bujalski L; Bronsted R
    Am J Crit Care; 1996 Nov; 5(6):449-54. PubMed ID: 8922161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of peripheral nerve stimulation versus standard clinical assessment for dosing of neuromuscular blocking agents.
    Murray MJ
    Crit Care Med; 1997 Apr; 25(4):561-2. PubMed ID: 9142016
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacoeconomic issues of sedation, analgesia, and neuromuscular blockade in critical care.
    Armstrong DK; Crisp CB
    New Horiz; 1994 Feb; 2(1):85-93. PubMed ID: 7922434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of continuous lateral rotation therapy in overall clinical and financial outcomes of critically ill patients.
    Swadener-Culpepper L; Skaggs RL; Vangilder CA
    Crit Care Nurs Q; 2008; 31(3):270-9. PubMed ID: 18574374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients.
    Prielipp RC; Coursin DB; Scuderi PE; Bowton DL; Ford SR; Cardenas VJ; Vender J; Howard D; Casale EJ; Murray MJ
    Anesth Analg; 1995 Jul; 81(1):3-12. PubMed ID: 7598277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient outcomes for the chronically critically ill: special care unit versus intensive care unit.
    Rudy EB; Daly BJ; Douglas S; Montenegro HD; Song R; Dyer MA
    Nurs Res; 1995; 44(6):324-31. PubMed ID: 7501485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of epidural lidocaine injection on vecuronium-induced neuromuscular blockade].
    Munakata K; Suzuki T; Watanabe N; Nagai H; Kakishita M; Saeki S; Ogawa S
    Masui; 2004 Dec; 53(12):1377-80. PubMed ID: 15682798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inconsistency with train-of-four monitoring in a critically ill paralyzed patient.
    Tschida SJ; Hoey LL; Vance-Bryan K
    Pharmacotherapy; 1995; 15(4):540-5. PubMed ID: 7479211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of practice guidelines on prescribing patterns of nondepolarizing neuromuscular blocking agents.
    Tschida SJ; Hoey LL; Vance-Bryan K
    Pharmacotherapy; 1996; 16(5):899-904. PubMed ID: 8888085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.